[go: up one dir, main page]

CN111072565A - A kind of 3-alkylpyrazole and preparation method thereof - Google Patents

A kind of 3-alkylpyrazole and preparation method thereof Download PDF

Info

Publication number
CN111072565A
CN111072565A CN201911320208.0A CN201911320208A CN111072565A CN 111072565 A CN111072565 A CN 111072565A CN 201911320208 A CN201911320208 A CN 201911320208A CN 111072565 A CN111072565 A CN 111072565A
Authority
CN
China
Prior art keywords
compound
reaction
preparation
alkylpyrazole
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201911320208.0A
Other languages
Chinese (zh)
Inventor
泮廷廷
王海波
韩强
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jinan Shaoyuan Medical Technology Co ltd
Original Assignee
Jinan Shaoyuan Medical Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jinan Shaoyuan Medical Technology Co ltd filed Critical Jinan Shaoyuan Medical Technology Co ltd
Priority to CN201911320208.0A priority Critical patent/CN111072565A/en
Publication of CN111072565A publication Critical patent/CN111072565A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

本发明涉及一种3‑烷基吡唑及其制备方法,所述制备方法包括如下步骤:(1)使化合物A与化合物B反应,得到化合物C‑1和C‑2的混合物;(2)向所述化合物C‑1和C‑2的混合物中加入无机酸,无机酸与化合物C‑2反应,分离后得到化合物C‑1;(3)向所述化合物C‑1中加入水合肼,反应得到3‑烷基吡唑。本发明旨在步骤(2)中加入无机酸,无机酸不能与化合物C‑1反应,却能够与其异构体化合物C‑2进行反应,从而除去化合物C‑2,得到纯的化合物C‑1,再进行最后一步关环反应即可得到纯度较高的3‑烷基吡唑,纯度>95%,且反应步骤简单,操作方便。The present invention relates to a 3-alkylpyrazole and a preparation method thereof. The preparation method comprises the following steps: (1) reacting compound A with compound B to obtain a mixture of compounds C-1 and C-2; (2) Add a mineral acid to the mixture of the compounds C-1 and C-2, and the mineral acid reacts with the compound C-2 to obtain compound C-1 after separation; (3) adding hydrazine hydrate to the compound C-1, The reaction obtains 3-alkylpyrazole. The present invention aims to add inorganic acid in step (2), and the inorganic acid cannot react with compound C-1, but can react with its isomer compound C-2, thereby removing compound C-2 to obtain pure compound C-1 3-alkylpyrazole with higher purity can be obtained by carrying out the final step of ring-closing reaction, the purity is more than 95%, and the reaction steps are simple and the operation is convenient.

Description

3-alkyl pyrazole and preparation method thereof
Technical Field
The invention relates to the technical field of organic synthesis, in particular to 3-alkyl pyrazole and a preparation method thereof.
Background
Pyrazole compounds have high biological activity and are attracting more and more attention as medicines, pesticides and the like. In particular to 3-alkyl pyrazole, one of important organic intermediates of a bifunctional chelating agent required to be used in time-resolved fluorescence immunoassay, 3-alkyl pyrazole and derivatives thereof can be used as a nitrogen fertilizer nitrification inhibitor, an acid gas absorbent, a precious metal extractant and a corrosion inhibitor, can also be used for separating and recovering alkyne, preparing pesticides with weeding performance and antibiotic action and fruit growth hormone, and can be used as an organic intermediate for synthesizing luminescent materials, the pyrazole derivatives have wide application, become a hotspot of development in recent years, and the synthesis of the pyrazole compounds is also concerned by the industry.
The synthesis method in the prior art comprises the following steps: the synthesis method comprises the steps of firstly synthesizing methyl formate by using formic acid and absolute ethyl alcohol and using calcium chloride as a catalyst, synthesizing formylacetone by using the methyl formate as a raw material and performing aldol condensation reaction on the methyl formate and acetone by using metal sodium and the absolute ethyl alcohol as catalysts, and finally adding hydrazine hydrate into the formylacetone to perform cyclization reaction to generate the product 3-methylpyrazole.
In addition, the prior art also discloses a simple preparation method of 3-alkyl pyrazole by the following two steps:
(1) the literature reports (Journal of Organic Chemistry,1955, vol.20, p.1681,1682) that starting from monoalkyl-substituted acetone, ethyl formate gives intermediate A1, and that A1 is cyclized with hydrazine hydrate to give 3-alkylpyrazole B1, the reaction is shown in scheme one below:
route one:
Figure BDA0002326925180000021
(2) KR101798840 discloses the reaction of monoalkyl-substituted acetone with N, N-dimethylformamide dimethyl acetal to obtain intermediate C1, and cyclization of C1 with hydrazine hydrate to obtain 3-alkylpyrazole B1, as shown in scheme II below:
Figure BDA0002326925180000022
both of the above-mentioned preparation methods, although simple in steps, have the drawback that 10-20% of the isomer A2 or C2 is produced in the first reaction step, followed by 10-20% of the isomer B2 in the second reaction step. The properties of B1 and B2 are very similar, so that the isomer impurity B2 is difficult to remove to obtain pure B1, and the purity of the obtained 3-alkyl pyrazole product is low.
Therefore, there is a need in the art to develop a method for preparing 3-alkylpyrazole with simple steps to improve the purity of the product.
Disclosure of Invention
The invention aims to provide a preparation method of 3-alkyl pyrazole, which has high purity of the 3-alkyl pyrazole and simple steps.
In order to achieve the purpose, the invention adopts the following technical scheme:
the invention provides a preparation method of 3-alkyl pyrazole, which comprises the following steps:
(1) reacting compound A with compound B to obtain a mixture of compounds C-1 and C-2, according to the following reaction formula:
Figure BDA0002326925180000031
r is selected from C1-C10 (such as C2, C3, C4, C5, C6, C7, C8, C9 and the like) alkyl; C1-C10 represent the number of carbons in the alkyl group;
(2) adding inorganic acid into the mixture of the compounds C-1 and C-2, reacting the inorganic acid with the compound C-2, and separating to obtain a compound C-1;
(3) adding hydrazine hydrate into the compound C-1, and reacting to obtain 3-alkyl pyrazole, wherein the reaction formula is as follows:
Figure BDA0002326925180000032
the invention provides a novel method for synthesizing 3-alkyl pyrazole, which comprises the steps of adding inorganic acid into the step (2), wherein the inorganic acid can not react with a compound C-1 but can react with an isomer compound C-2 thereof, so that the compound C-2 is removed to obtain a pure compound C-1, and then carrying out a final ring-closing reaction to obtain the 3-alkyl pyrazole with higher purity, wherein the purity is more than 95 percent, and the reaction steps are simple and convenient to operate.
Preferably, the inorganic acid comprises any one or a combination of at least two of hydrochloric acid, sulfuric acid or nitric acid, preferably hydrochloric acid.
The invention preferably uses hydrochloric acid to react with the compound C-2, and can react with the compound C-2 more completely, thereby further improving the purity of the 3-alkyl pyrazole.
Preferably, the concentration of the hydrochloric acid is 2-5 mol/L, such as 2.1mol/L, 2.2mol/L, 2.3mol/L, 2.5mol/L, 2.6mol/L, 2.8mol/L, 2.9mol/L, 3mol/L, 3.2mol/L, 3.5mol/L, 3.7mol/L, 3.9mol/L, 4mol/L, 4.2mol/L, 4.6mol/L, 4.8mol/L, and the like, and 3mol/L is preferred.
The hydrochloric acid preferably has the specific concentration, the purity of the 3-alkyl pyrazole can be further improved within the concentration range, the concentration of the hydrochloric acid is too high, C-1 is damaged, the selectivity of the reaction is poor, the purity of the final product is reduced, the concentration of the hydrochloric acid is too low, the reaction with C-2 cannot be carried out, and the subsequent extraction difficulty is increased due to too much added water.
Preferably, the molar ratio of the inorganic acid to the compound a is (0.05-0.20): 1, for example, 0.06:1, 0.07:1, 0.08:1, 0.09:1, 0.1:1, 0.11:1, 0.12:1, 0.13:1, 0.14:1, 0.15:1, 0.16:1, 0.17:1, 0.18:1, 0.19:1, and the like.
In the present invention, it is preferable to add the inorganic acid in the above-mentioned addition ratio, and within this ratio, the purity of the 3-alkylpyrazole can be further improved, and too much inorganic acid causes C-1 loss, while too little inorganic acid causes a decrease in yield and a decrease in purity.
Preferably, in the step (2), the inorganic acid is added in a dropwise manner to the mixture of the compounds C-1 and C-2.
Preferably, in step (2), the solvent of the reaction comprises water.
Preferably, in step (2), the temperature of the reaction is < 10 ℃, e.g., 0 ℃,1 ℃, 2 ℃, 3 ℃,4 ℃, 5 ℃, 6 ℃, 7 ℃, 8 ℃, 9 ℃, etc.
The reaction of step (2) is preferably carried out at a low temperature (< 10 ℃) in the present invention because, when the temperature is too high, the inorganic acid reacts with both C-1 and C-2, the selectivity is deteriorated, resulting in a decrease in yield and a decrease in purity of the final product.
Preferably, in the step (2), the reaction time is 20-40 min, such as 21min, 22min, 23min, 24min, 25min, 26min, 27min, 28min, 29min, 30min, 31min, 32min, 33min, 34min, 35min, 36min, 37min, 38min, 39min, and the like, and preferably 30 min.
Preferably, in the step (2), after the reaction is completed, a base is added to the reaction system to adjust the pH.
Preferably, the base comprises any one or a combination of at least two of potassium carbonate, sodium hydroxide, strong potassium oxide or lithium hydroxide.
Preferably, the pH is adjusted to 10-11.
Preferably, the extraction, washing, drying, distillation is carried out after the pH adjustment.
Preferably, the solvent of the extraction comprises ethyl acetate.
Preferably, the washing detergent comprises a saturated saline solution.
Preferably, the step (2) specifically comprises the following steps:
dispersing a mixture of the compounds C-1 and C-2 in water, dropwise adding hydrochloric acid with the concentration of 2-5 mol/L at the temperature of less than 10 ℃, stirring for 20-40 min, then adding alkali to adjust the pH value to 10-11, extracting, washing, drying and distilling to obtain the compound C-1.
Preferably, in the step (1), the solvent for the reaction includes any one or a combination of at least two of N, N-dimethylformamide, N-dimethylacetamide, N-methylpyrrolidone, or dimethylsulfoxide.
Preferably, in step (1), the reaction is carried out under nitrogen protection.
Preferably, in the step (1), the reaction temperature is 100 to 150 ℃, for example 105 ℃, 110 ℃, 115 ℃, 120 ℃, 125 ℃, 130 ℃, 135 ℃, 140 ℃, 145 ℃, 148 ℃ and the like, preferably 125 ℃.
Preferably, in the step (1), the reaction time is 20-25 h, such as 21h, 22h, 23h, 24h, 25h and the like, and preferably 24 h.
Preferably, the step (1) specifically comprises the following steps:
and mixing the compound A, the compound B and a solvent, heating to 100-150 ℃ under the protection of nitrogen, and stirring for 20-25 h to obtain a mixture of the compounds C-1 and C-2.
Preferably, in the step (3), the solvent for the reaction includes any one or a combination of at least two of ethanol, methanol, isopropanol, 1, 4-dioxane, acetonitrile, tetrahydrofuran, 2-methyltetrahydrofuran, or n-butanol.
Preferably, in step (3), the temperature of the reaction is 70 to 90 ℃, such as 71 ℃, 72 ℃, 73 ℃, 74 ℃, 75 ℃, 76 ℃, 77 ℃, 78 ℃, 79 ℃, 80 ℃, 81 ℃, 82 ℃, 83 ℃, 84 ℃, 85 ℃, 86 ℃, 87 ℃, 88 ℃, 89 ℃, preferably 85 ℃.
Preferably, in step (3), the reaction time is 4-6 h, such as 4.1h, 4.2h,. 3h,. 4h, 4.5h, 4.6h, 4.7h, 4.8h, 4.9h, 5h, 5.1h, 5.2h, 5.3h, 5.4h, 5.5h, 5.6h, 5.7h, 5.8h, 5.9h, and the like, preferably 5 h.
Preferably, the step (3) specifically comprises the following steps:
and mixing the compound C-1, hydrazine hydrate and a solvent, heating to 70-90 ℃, and stirring for 4-6 hours to obtain the 3-alkyl pyrazole.
Preferably, the preparation method specifically comprises the following steps:
(1) mixing the compound A, the compound B and a solvent, heating to 100-150 ℃ under the protection of nitrogen, and stirring for 20-25 h to obtain a mixture of compounds C-1 and C-2;
(2) dispersing a mixture of a compound C-1 and a compound C-2 in water, dropwise adding hydrochloric acid with the concentration of 2-5 mol/L at the temperature of less than 10 ℃, stirring for 20-40 min, then adding alkali to adjust the pH value to 10-11, extracting, washing, drying and distilling to obtain a compound C-1;
(3) and mixing the compound C-1, hydrazine hydrate and a solvent, heating to 70-90 ℃, and stirring for 4-6 hours to obtain the 3-alkyl pyrazole.
It is a second object of the present invention to provide a 3-alkylpyrazole, which is produced by the production method described in the first object.
Preferably, the 3-alkylpyrazole is > 95% pure, e.g., 95.5%, 96%, 96.5%, 97%, 97.5%, 98%, 98.5%, 99%, 99.5%, 99.8%, etc.
Compared with the prior art, the invention has the following beneficial effects:
the invention provides a new method for synthesizing 3-alkyl pyrazole, which is characterized in that inorganic acid is added in the step (2), the inorganic acid can not react with a compound C-1 but can react with an isomer compound C-2 thereof, so that the compound C-2 is removed to obtain a pure compound C-1, and then hydrazine hydrate cyclization reaction is carried out in the last step to obtain the 3-alkyl pyrazole with higher purity, wherein the purity is more than 95 percent, and the reaction steps are simple and the operation is convenient.
Detailed Description
The technical solution of the present invention is further explained by the following embodiments. It should be understood by those skilled in the art that the examples are only for the understanding of the present invention and should not be construed as the specific limitations of the present invention.
In the present invention, the compounds were characterized using a gas chromatograph model 7890B from Agilent and a nuclear magnetic resonance spectrometer model 400-MR from Warran.
Example 1
This example provides a preparation method of 3-propylpyrazole, which comprises the following steps:
Figure BDA0002326925180000071
(1) 2500g of N, N-dimethylformamide dimethyl acetal (21mol, 1.0eq), 2000g of 2-pentanone (23.1mol, 1.1eq) and 2.0L of N, N-Dimethylformamide (DMF) are mixed, the temperature is raised to 125 ℃ under the protection of nitrogen, the mixture is stirred for 24 hours, Gas Chromatography (GC) detects that the N, N-dimethylformamide dimethyl acetal has little residue and is completely reacted basically, and the isomer C-2 accounts for about 16 percent. Heating was stopped, the mixture was cooled to 60 ℃ and the solvent was removed by rotary evaporation to obtain 1420g of crude product.
(2) Dispersing 1420g (10.1mol, 1.0eq) of crude product obtained in the step (1) in 6.0L of ice water, keeping the temperature within 10 ℃, slowly adding 600mL of 3mol/L hydrochloric acid (1.8mol, 0.18eq) dropwise, keeping the temperature and stirring for 30min, sampling and detecting by thin layer chromatography (TLC, developing agent: dichloromethane, Rf product is 0.3, tailing, Rf isomer is 0.45), remaining a small amount of isomer C-2, continuing to add 50mL of 3mol/L hydrochloric acid dropwise, stirring for 30min, and detecting by TLC that the isomer C-2 is completely reacted. 1kg of potassium carbonate solid was added to the system directly in portions, the pH was adjusted to 10, and 2.5 L.times.3 extraction with ethyl acetate was carried out. The organic phases are combined, washed twice with saturated salt water, dried and spin-dried. 1030g of compound C-1 are obtained. The purity is 95% by GC detection, and the isomer C-2 accounts for less than 1%.
(3) Adding 1030g (7.31mol, 1.0eq) of the mixture into a 10L three-necked bottle, mechanically stirring, adding 4.85L of ethanol, adding 385g of 85% hydrazine hydrate (10.22mol, 1.4eq), heating to 85 ℃, refluxing and stirring for more than 5 hours, carrying out GC detection until the raw materials disappear, carrying out rotary evaporation to remove the solvent after the reaction is finished, carrying out oil pump drying, carrying out reduced pressure distillation, collecting fractions (0.5torr) at 85-100 ℃, obtaining 680g of light yellow liquid, namely 3-propylpyrazole, wherein the purity is 97.5% by GC detection.
Mass spectrum of compound 3-propylpyrazole: [ M +1] + ═ 111.2;
nuclear magnetic resonance hydrogen spectrum of compound 3-propylpyrazole:1HNMR(400MHz,CD3OD)δ:7.47(s,1H),6.09(s,1H),2.63(t,J=7.5Hz,1H),1.80–1.56(m,1H),0.96(t,J=7.4Hz,2H)。
example 2
The difference from example 1 is that the concentration of hydrochloric acid was 2mol/L and the purity of 3-methylpyrazole was 97.3%.
Example 3
The difference from example 1 is that the concentration of hydrochloric acid was 5mol/L and the purity of 3-methylpyrazole was 97.1%.
Example 4
The difference from example 1 is that the concentration of hydrochloric acid was 1mol/L and the purity of 3-methylpyrazole was 95.1%.
Example 5
The difference from example 1 is that the concentration of hydrochloric acid was 6mol/L and the purity of 3-methylpyrazole was 95.0%.
Example 6
The difference from example 1 is that, in step (2), hydrochloric acid was added dropwise at a temperature of 15 ℃ and the purity of 3-methylpyrazole was 95.2%.
Example 7
This example provides a preparation method of 3-propylpyrazole, which comprises the following steps:
Figure BDA0002326925180000091
(1) 2500g of N, N-dimethylformamide dimethyl acetal (21mol, 1.0eq), 2000g of 2-pentanone (23.1mol, 1.1eq) and 2.0L of N, N-Dimethylformamide (DMF) are mixed, the temperature is raised to 100 ℃ under the protection of nitrogen, the mixture is stirred for 25 hours, Gas Chromatography (GC) detects that the N, N-dimethylformamide dimethyl acetal has little residue and is completely reacted basically, and the isomer C-2 accounts for about 15%. Heating is stopped, the temperature is cooled to 60 ℃, and the solvent is removed by rotary evaporation to obtain 1390g of crude product.
(2) 1390g (9.8mol, 1.0eq) of crude product obtained in the step (1) is dispersed in 6.0L of ice water, 600mL of 3mol/L hydrochloric acid (1.81mol, 0.18eq) is slowly added dropwise while keeping the temperature within 10 ℃, the mixture is kept and stirred for 20min, sampling thin layer chromatography (TLC, developing agent: dichloromethane, Rf product is 0.3, tailing, Rf isomer is 0.45) is detected, a small amount of isomer C-2 is remained, 50mL of 3mol/L hydrochloric acid is continuously added dropwise, stirring is carried out for 30min, and the isomer C-2 is detected by TLC to be completely reacted. 1kg of potassium carbonate solid was added to the system directly in portions, the pH was adjusted to 11, and 2.5 L.times.3 extraction with ethyl acetate was carried out. The organic phases are combined, washed twice with saturated salt water, dried and spin-dried. 1010g of compound C-1 were obtained. The purity is 96 percent by GC detection, and the isomer C-2 accounts for less than 1 percent.
(3) Adding 1010g (7.15mol, 1.0eq) of the crude product into a 10L three-necked bottle, mechanically stirring, adding 4.85L of ethanol, adding 377g of 85% hydrazine hydrate (10.01mol, 1.4eq), heating to 70 ℃, refluxing and stirring for more than 6h, carrying out GC detection until the raw materials disappear, carrying out rotary evaporation to remove the solvent after the reaction is finished, carrying out oil pump drying, carrying out reduced pressure distillation, collecting fractions (0.5torr) at 85-100 ℃, obtaining 674g of light yellow liquid, namely 3-propylpyrazole, wherein the GC detection purity is 97.0%.
Example 8
This example provides a preparation method of 3-propylpyrazole, which comprises the following steps:
Figure BDA0002326925180000101
(1) 2500g of N, N-dimethylformamide dimethyl acetal (21mol, 1.0eq), 2000g of 2-pentanone (23.1mol, 1.1eq) and 2.0L of N, N-Dimethylformamide (DMF) are mixed, the temperature is raised to 150 ℃ under the protection of nitrogen, the mixture is stirred for 20 hours, Gas Chromatography (GC) detects that the N, N-dimethylformamide dimethyl acetal has little residue and is completely reacted basically, and the isomer C-2 accounts for about 16 percent. Stopping heating, cooling to 60 ℃, and removing the solvent by rotary evaporation to obtain 1480g of a crude product.
(2) Dispersing 1480g (10.5mol, 1.0eq) of the crude product obtained in the step (1) in 6.0L of ice water, keeping the temperature within 10 ℃, slowly adding 600mL of 3mol/L hydrochloric acid (1.81mol, 0.17eq) dropwise, keeping the temperature and stirring for 40min, sampling and detecting by thin layer chromatography (TLC, developing agent: dichloromethane, Rf product is 0.3, tailing, Rf isomer is 0.45), remaining a small amount of isomer C-2, continuing adding 50mL of 3mol/L hydrochloric acid dropwise, stirring for 30min, and detecting by TLC that the isomer C-2 is completely reacted. 1kg of potassium carbonate solid was added to the system directly in portions, the pH was adjusted to 11, and 2.5 L.times.3 extraction with ethyl acetate was carried out. The organic phases are combined, washed twice with saturated salt water, dried and spin-dried. 1120g of Compound C-1 were obtained. The purity is 94% by GC detection, and the isomer C-2 accounts for less than 1%.
(3) 1120g (7.93mol, 1.0eq) is added into a 10L three-necked bottle, mechanical stirring is carried out, 4.85L of ethanol is added, 418g of 85% hydrazine hydrate (11.10mol, 1.4eq) is added, the temperature is raised to 70 ℃, reflux stirring is carried out for more than 6h, GC detection is carried out until the raw materials disappear, the reaction is finished, the solvent is removed by rotary evaporation, an oil pump is used for drying, reduced pressure distillation is carried out, fraction (0.5torr) at 85-100 ℃ is collected, and 689g of light yellow liquid, namely 3-propylpyrazole, is obtained, and the purity is 97.2% by GC detection.
The mass spectrum and nuclear magnetic characterization data of examples 2-8 are similar to those of example 1, which shows that 3-propylpyrazole is successfully synthesized, and are not repeated.
Example 9
This example provides a preparation method of 3-ethylpyrazole, which specifically includes the following steps:
Figure BDA0002326925180000111
(1) 420g of 2-butanone (5.8mol, 1.1eq), 622g N, N-dimethylformamide dimethyl acetal (5.22mol, 1.0eq) and 500ml of DMF are uniformly mixed, the temperature is raised to 125 ℃ under the protection of nitrogen, the mixture is stirred for 24 hours, Gas Chromatography (GC) detects that the N, N-dimethylformamide dimethyl acetal has little residue and complete basic reaction, and the isomer C-2 accounts for about 15 percent. Stopping heating, cooling to 60 ℃, and removing the solvent by rotary evaporation to obtain 311g of crude product;
(2) dispersing 311g (2.45mol, 1.0eq) crude product obtained in the step (1) in 1.5L of ice water, keeping the temperature within 10 ℃, slowly adding 150mL of 3mol/L hydrochloric acid (0.45mol, 0.18eq) dropwise, keeping the temperature and stirring for 30min, sampling and detecting by thin layer chromatography (TLC, developing agent: dichloromethane, Rf product is 0.3, tailing, Rf isomer is 0.45), remaining a small amount of isomer C-2, continuing to add 12mL of 3mol/L hydrochloric acid dropwise, stirring for 30min, and detecting by TLC that the isomer C-2 is completely reacted. 0.25kg of potassium carbonate solid was added to the system in portions directly, the pH was adjusted to 10, and ethyl acetate was extracted at 0.6 L.times.3. The organic phases are combined, washed twice with saturated salt water, dried and spin-dried. 226g of compound C-1 are obtained. The purity is 96 percent by GC detection, and the isomer C-2 accounts for less than 1 percent.
(3) 226g (1.78mol, 1.0eq) of the mixture is added into a 10L three-necked bottle, the mixture is mechanically stirred, 1.2L of ethanol is added, 94g of 85 percent hydrazine hydrate (2.49mol, 1.4eq) is added, the mixture is heated to 85 ℃, the reflux stirring is carried out for more than 5 hours, GC detection is carried out until the raw materials disappear, the reaction is finished, the solvent is removed by rotary evaporation, an oil pump is used for drying, reduced pressure distillation is carried out, fractions at 85-100 ℃ are collected (0.5torr), 142g of light yellow liquid, namely 3-ethylpyrazole is obtained, and the purity of GC detection is 97.8%.
Mass Spectrometry of Compound 3-ethylpyrazole: [ M +1]]+=97.1;
Nuclear magnetic resonance hydrogen spectrum of compound 3-ethylpyrazole:1HNMR(400MHz,CD3OD)δ:7.49(s,1H),6.09(s,1H),2.71(t,J=7.5Hz,1H),1.27(t,J=7.4Hz,2H)。
comparative example 1
The difference from example 1 is that, without carrying out step (2), the 3-methylpyrazole purity was 83.2%.
As is clear from the above examples and comparative examples, the present invention can remove the isomer C-2 by introducing the step (2), and further improve the purity (> 95%) of the final product 3-methylpyrazole, and further, the purity can be more than 97% under preferable conditions.
As is clear from comparative examples 1 to 5, when the concentration of hydrochloric acid is 2 to 5mol/L (examples 1 to 3), the purity of the finally obtained 3-methylpyrazole is further improved, and the purity is lowered both when the concentration is too low (example 4) and when the concentration is too high (example 5).
Comparing example 1 with example 6, it can be seen that the purity can be further improved by controlling the temperature of the dropwise addition hydrochloric acid to 10 ℃ or lower (example 1), and increasing the dropwise addition temperature to 15 ℃ (example 6).
The present invention is illustrated in detail by the examples described above, but the present invention is not limited to the details described above, i.e., it is not intended that the present invention be implemented by relying on the details described above. It should be understood by those skilled in the art that any modification of the present invention, equivalent substitutions of the raw materials of the product of the present invention, addition of auxiliary components, selection of specific modes, etc., are within the scope and disclosure of the present invention.

Claims (10)

1.一种3-烷基吡唑的制备方法,其特征在于,所述制备方法包括如下步骤:1. a preparation method of 3-alkylpyrazole, is characterized in that, described preparation method comprises the steps: (1)使化合物A与化合物B反应,得到化合物C-1和C-2的混合物,反应式如下:(1) make compound A react with compound B, obtain the mixture of compound C-1 and C-2, reaction formula is as follows:
Figure FDA0002326925170000011
Figure FDA0002326925170000011
所述R选自C1~C10烷基;Described R is selected from C1~C10 alkyl; (2)向所述化合物C-1和C-2的混合物中加入无机酸,无机酸与化合物C-2反应,分离后得到化合物C-1;(2) adding an inorganic acid to the mixture of the compounds C-1 and C-2, the inorganic acid reacts with the compound C-2, and after separation, the compound C-1 is obtained; (3)向所述化合物C-1中加入水合肼,反应得到3-烷基吡唑,反应式如下:(3) adding hydrazine hydrate to the compound C-1, the reaction obtains 3-alkylpyrazole, and the reaction formula is as follows:
Figure FDA0002326925170000012
Figure FDA0002326925170000012
2.根据权利要求1所述的制备方法,其特征在于,所述无机酸包括盐酸、硫酸或硝酸中的任意一种或至少两种组合,优选盐酸;2. preparation method according to claim 1, is characterized in that, described mineral acid comprises any one or at least two combinations in hydrochloric acid, sulfuric acid or nitric acid, preferably hydrochloric acid; 优选地,所述盐酸的浓度为2~5mol/L,优选3mol/L;Preferably, the concentration of the hydrochloric acid is 2~5mol/L, preferably 3mol/L; 优选地,所述无机酸与化合物A的摩尔比为(0.05~0.20):1。Preferably, the molar ratio of the inorganic acid to compound A is (0.05-0.20):1. 3.根据权利要求1或2所述的制备方法,其特征在于,步骤(2)中,所述无机酸以滴加的形式加入至化合物C-1和C-2的混合物中。3. The preparation method according to claim 1 or 2, characterized in that, in step (2), the inorganic acid is added dropwise to the mixture of compounds C-1 and C-2. 4.根据权利要求1~3中任一项所述的制备方法,其特征在于,步骤(2)中,所述反应的溶剂包括水;4. The preparation method according to any one of claims 1 to 3, wherein in step (2), the solvent of the reaction comprises water; 优选地,步骤(2)中,所述反应的温度<10℃;Preferably, in step (2), the temperature of the reaction is less than 10°C; 优选地,步骤(2)中,所述反应的时间为20~40min,优选30min。Preferably, in step (2), the reaction time is 20-40 min, preferably 30 min. 5.根据权利要求1~4中任一项所述的制备方法,其特征在于,步骤(2)中,所述反应完成后,在反应体系中加入碱,调节pH;5. The preparation method according to any one of claims 1 to 4, wherein in step (2), after the reaction is completed, an alkali is added to the reaction system to adjust pH; 优选地,所述碱包括碳酸钾、碳酸钠、氢氧化钠、强氧化钾或氢氧化锂中的任意一种或至少两种组合;Preferably, the alkali comprises any one or a combination of at least two of potassium carbonate, sodium carbonate, sodium hydroxide, strong potassium oxide or lithium hydroxide; 优选地,调节pH至10~11;Preferably, the pH is adjusted to 10-11; 优选地,在调节pH之后进行萃取,洗涤,干燥,蒸馏;Preferably, extraction, washing, drying, distillation are carried out after adjusting the pH; 优选地,所述萃取的溶剂包括乙酸乙酯;Preferably, the solvent of the extraction comprises ethyl acetate; 优选地,所述洗涤的洗涤剂包括饱和食盐水;Preferably, the washing detergent includes saturated brine; 优选地,步骤(2)具体包括如下步骤:Preferably, step (2) specifically includes the following steps: 将化合物C-1和C-2的混合物分散于水中,在<10℃的温度下滴加浓度为2~5mol/L的盐酸,搅拌20~40min,随后加入碱调节pH至10~11,萃取,洗涤,干燥,蒸馏,得到化合物C-1。Disperse the mixture of compounds C-1 and C-2 in water, dropwise add hydrochloric acid with a concentration of 2 to 5 mol/L at a temperature of <10 ° C, stir for 20 to 40 min, then add alkali to adjust the pH to 10 to 11, extract , washed, dried and distilled to obtain compound C-1. 6.根据权利要求1~5中任一项所述的制备方法,其特征在于,步骤(1)中,所述反应的溶剂包括N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、N-甲基吡咯烷酮或二甲基亚砜中的任意一种或至少两种组合;6. The preparation method according to any one of claims 1 to 5, wherein in step (1), the solvent of the reaction comprises N,N-dimethylformamide, N,N-dimethylformamide any one or a combination of at least two of acetamide, N-methylpyrrolidone or dimethyl sulfoxide; 优选地,步骤(1)中,所述反应在氮气保护下进行;Preferably, in step (1), the reaction is carried out under nitrogen protection; 优选地,步骤(1)中,所述反应的温度为100~150℃,优选125℃;Preferably, in step (1), the temperature of the reaction is 100-150°C, preferably 125°C; 优选地,步骤(1)中,所述反应的时间为20~25h,优选24h;Preferably, in step (1), the reaction time is 20-25h, preferably 24h; 优选地,步骤(1)具体包括如下步骤:Preferably, step (1) specifically includes the following steps: 将化合物A、化合物B和溶剂混合,在氮气的保护下升温至100~150℃,搅拌20~25h,得到化合物C-1和C-2的混合物。Compound A, compound B and solvent are mixed, heated to 100-150° C. under the protection of nitrogen, and stirred for 20-25 h to obtain a mixture of compounds C-1 and C-2. 7.根据权利要求1~6中任一项所述的制备方法,其特征在于,步骤(3)中,所述反应的溶剂包括乙醇、甲醇、异丙醇、1,4-二氧六环、乙腈、四氢呋喃、2-甲基四氢呋喃或正丁醇中的任意一种或至少两种组合;7. The preparation method according to any one of claims 1 to 6, wherein in step (3), the solvent of the reaction comprises ethanol, methanol, isopropanol, 1,4-dioxane , any one or a combination of at least two in acetonitrile, tetrahydrofuran, 2-methyltetrahydrofuran or n-butanol; 优选地,步骤(3)中,所述反应的温度为70~90℃,优选85℃;Preferably, in step (3), the temperature of the reaction is 70-90°C, preferably 85°C; 优选地,步骤(3)中,所述反应的时间为4~6h,优选5h;Preferably, in step (3), the reaction time is 4-6h, preferably 5h; 优选地,步骤(3)具体包括如下步骤:Preferably, step (3) specifically includes the following steps: 将化合物C-1、水合肼和溶剂混合,升温至70~90℃,搅拌4~6h,得到所述3-烷基吡唑。Compound C-1, hydrazine hydrate and solvent are mixed, the temperature is raised to 70-90° C., and stirred for 4-6 h to obtain the 3-alkylpyrazole. 8.根据权利要求1~7中任一项所述的制备方法,其特征在于,所述制备方法具体包括如下步骤:8. The preparation method according to any one of claims 1 to 7, wherein the preparation method specifically comprises the following steps: (1)将化合物A、化合物B和溶剂混合,在氮气的保护下升温至100~150℃,搅拌20~25h,得到化合物C-1和C-2的混合物;(1) Mixing compound A, compound B and a solvent, heating to 100-150° C. under the protection of nitrogen, stirring for 20-25 h, to obtain a mixture of compounds C-1 and C-2; (2)将化合物C-1和C-2的混合物分散于水中,在<10℃的温度下滴加浓度为2~5mol/L的盐酸,搅拌20~40min,随后加入碱调节pH至10~11,萃取,洗涤,干燥,蒸馏,得到化合物C-1;(2) Disperse the mixture of compounds C-1 and C-2 in water, dropwise add hydrochloric acid with a concentration of 2 to 5 mol/L at a temperature of <10°C, stir for 20 to 40 min, and then add an alkali to adjust the pH to 10 to 10 11. Extraction, washing, drying and distillation to obtain compound C-1; (3)将化合物C-1、水合肼和溶剂混合,升温至70~90℃,搅拌4~6h,得到所述3-烷基吡唑。(3) Compound C-1, hydrazine hydrate and solvent are mixed, the temperature is raised to 70-90° C., and stirred for 4-6 h to obtain the 3-alkylpyrazole. 9.一种3-烷基吡唑,其特征在于,所述3-烷基吡唑通过权利要求1~8中任一项所述的制备方法制备得到。9 . A 3-alkylpyrazole, characterized in that, the 3-alkylpyrazole is prepared by the preparation method according to any one of claims 1 to 8 . 10.根据权利要求9所述的3-烷基吡唑,其特征在于,所述3-烷基吡唑的纯度>95%。10 . The 3-alkylpyrazole according to claim 9 , wherein the purity of the 3-alkylpyrazole is greater than 95%. 11 .
CN201911320208.0A 2019-12-19 2019-12-19 A kind of 3-alkylpyrazole and preparation method thereof Pending CN111072565A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911320208.0A CN111072565A (en) 2019-12-19 2019-12-19 A kind of 3-alkylpyrazole and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911320208.0A CN111072565A (en) 2019-12-19 2019-12-19 A kind of 3-alkylpyrazole and preparation method thereof

Publications (1)

Publication Number Publication Date
CN111072565A true CN111072565A (en) 2020-04-28

Family

ID=70315939

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911320208.0A Pending CN111072565A (en) 2019-12-19 2019-12-19 A kind of 3-alkylpyrazole and preparation method thereof

Country Status (1)

Country Link
CN (1) CN111072565A (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6022979A (en) * 1998-07-15 2000-02-08 Basf Aktiengesellschaft Process for preparing pyrazoles
JP2006315959A (en) * 2005-05-10 2006-11-24 Ube Ind Ltd Method for obtaining 4-substituted-1-N, N-dialkylamino-1-buten-3-one
TW201139381A (en) * 2009-12-23 2011-11-16 K & S Ag Process for the cleaning of pyrazoles
CN109476664A (en) * 2017-05-17 2019-03-15 乐高化学生物科学股份有限公司 Novel compounds as autotaxin inhibitors and pharmaceutical compositions containing the same
CN110218188A (en) * 2019-05-21 2019-09-10 武威金仓生物科技有限公司 A kind of 3,4- dimethyl pyrazole and 3,4- dimethyl pyrazole method for production of phosphate salt
CN110483400A (en) * 2019-08-14 2019-11-22 上海应用技术大学 A kind of preparation method of pyrazole derivatives

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6022979A (en) * 1998-07-15 2000-02-08 Basf Aktiengesellschaft Process for preparing pyrazoles
JP2006315959A (en) * 2005-05-10 2006-11-24 Ube Ind Ltd Method for obtaining 4-substituted-1-N, N-dialkylamino-1-buten-3-one
TW201139381A (en) * 2009-12-23 2011-11-16 K & S Ag Process for the cleaning of pyrazoles
CN109476664A (en) * 2017-05-17 2019-03-15 乐高化学生物科学股份有限公司 Novel compounds as autotaxin inhibitors and pharmaceutical compositions containing the same
CN110218188A (en) * 2019-05-21 2019-09-10 武威金仓生物科技有限公司 A kind of 3,4- dimethyl pyrazole and 3,4- dimethyl pyrazole method for production of phosphate salt
CN110483400A (en) * 2019-08-14 2019-11-22 上海应用技术大学 A kind of preparation method of pyrazole derivatives

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ALBERTO BARGAGNA,等: "Reaction of sulfene and dichloroketene with open-chain N,N-disubstituted α-aminomethylene ketones. Synthesis of 4-dialkylamino-3,4-dihydro-5,6-dimethyl-1,2-oxathiin 2,2-dioxides and of 6,(5)-(di)alkyl-3-chloro-4-(methylphenylamino)-2H-pyran-2-ones", 《JOURNAL OF HETEROCYCLIC CHEMISTRY》 *
LECHK OZERSKI等: "CONFORMATIONAL STUDIES BY NUCLEAR MAGNETIC resonance. III. ASIS [aromatic solvent induced shift] and protonation studies of the rotational isomerism of enamino aldehydes and ketones", 《ORGANIC MAGNETIC RESONANCE》 *

Similar Documents

Publication Publication Date Title
JP2023524626A (en) Method for synthesizing roxadustat and intermediates thereof and intermediates thereof
WO2008015977A1 (en) PROCESS FOR PRODUCTION OF (±)-3a,6,6,9a– TETRAMETHYLDECAHYDRONAPHTHO[2,1-b]FURAN-2(1H)-ONE
CN111072565A (en) A kind of 3-alkylpyrazole and preparation method thereof
CN110642790B (en) Preparation method of rosuvastatin calcium and intermediate thereof
CN109232222B (en) A kind of preparation method of (E)-oct-4-ene-1,8-dioic acid
CN112125864B (en) Synthesis method of 1,1 &#39;-diamino-5, 5&#39; -bitetrazole
KR20100028543A (en) Process for preparing aromatase inhibitors
JP2019507156A (en) Process for producing 4-alkoxy-3-hydroxypicolinic acid
CN106883227A (en) The method that ergometrine is prepared by ergot fermentation waste
US9284249B2 (en) Method for extracting asymmetric β-diketone compound from β-diketone compound
CN114249679B (en) A method for preparing α,α-gedifluorocarbonyl compounds
CN119591653B (en) Synthesis method of 5 alpha-androstane-2-alkene-17-ketone
JP2004506628A (en) Intermediates for use in preparing vitamin E
CN111217709A (en) Preparation method of (1-fluorocyclopropyl) methylamine hydrochloride
CN112679512A (en) Tributine intermediate and preparation method thereof
CN112573999B (en) Preparation method of 3-chlorogentitol
CN120247659A (en) A method for preparing 4-(2-bromopropyl)benzene-1,2-diol
JP2512958B2 (en) 1-biphenylylethanol derivative and process for producing the same
CN118027091A (en) A preparation method of treprostinil and its intermediates
CN121537347A (en) A 6,7-dihydrocyclopentano[b]pyridin-5-one, its synthesis method and uses
WO2025133100A1 (en) Process for the preparation of intermediates useful for the preparation of tapinarof
US9683010B2 (en) Process for the production of 21-methoxy-11-beta-phenyl-19-nor-pregna-4,9-diene-3,20-dione derivatives
CN104974055B (en) The preparation method of the methyl glutamate derivatives of optical voidness 3
CN118146139A (en) Synthesis method of 4-amino-1-methylpiperidine
CN117624103A (en) A kind of synthesis method of (R)-6,8-dibromochroman-4-amine hydrochloride

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20200428

RJ01 Rejection of invention patent application after publication